Valneva to Present and Hold Investor Meetings at the Guggenheim Vaccines and Infectious Disease Conference
30 September 2021 - 5:45PM
Saint-Herblain
(France),
September 30,
2021 – Valneva SE (Nasdaq: VALN;
Euronext Paris: VLA), a specialty vaccine company, today announced
that its senior management will present and participate in 1-on-1
meetings with institutional investors at the Guggenheim Vaccines
and Infectious Disease Conference on October 6, 2021.
Valneva’s Chief Executive Officer Thomas
Lingelbach and acting Chief Financial Officer David Lawrence will
notably discuss the Company’s late stage vaccine candidates against
Lyme disease (VLA15), chikungunya (VLA1553) and COVID-19
(VLA2001).
Partnered with Pfizer (NYSE: PFE), VLA15 is the
only Lyme disease vaccine in clinical development worldwide while
VLA1553 is the only single-shot chikungunya vaccine candidate in
Phase 3 clinical trials and VLA2001 the only inactivated vaccine
candidate in clinical trials against COVID-19 in Europe.
To request a meeting at the event, please
contact your representative at Guggenheim.
About Valneva SEValneva is a
specialty vaccine company focused on the development and
commercialization of prophylactic vaccines for infectious diseases
with significant unmet medical need. The Company takes a highly
specialized and targeted approach to vaccine development and then
applies its deep understanding of vaccine science to develop
prophylactic vaccines addressing these diseases. Valneva has
leveraged its expertise and capabilities both to successfully
commercialize two vaccines and to rapidly advance a broad range of
vaccine candidates into and through the clinic, including
candidates against Lyme disease, the chikungunya virus and
COVID-19.
Valneva Investor and Media ContactsLaetitia
Bachelot-FontaineVP, Global Communications and European Investor
RelationsM +33 (0)6 4516
7099investors@valneva.com |
Joshua Drumm, Ph.D.VP, Global Investor RelationsM +001
917 815 4520joshua.drumm@valneva.com |
|
|
- 2021_09_30_VLA_Gugg_PR_EN_Final
Valneva (EU:VLA)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Valneva (EU:VLA)
Historical Stock Chart
Von Apr 2023 bis Apr 2024